Micropump integrated white blood cell separation platform for detection of chronic granulomatous disease

Mikrochim Acta. 2024 May 3;191(5):295. doi: 10.1007/s00604-024-06372-7.

Abstract

White blood cells (WBCs) are robust defenders during antigenic challenges and prime immune cell functioning indicators. High-purity WBC separation is vital for various clinical assays and disease diagnosis. Red blood cells (RBCs) are a major hindrance in WBC separation, constituting 1000 times the WBC population. The study showcases a low-cost micropump integrated microfluidic platform to provide highly purified WBCs for point-of-care testing. An integrated user-friendly microfluidic platform was designed to separate WBCs from finger-prick blood (⁓5 μL), employing an inertial focusing technique. We achieved an efficient WBC separation with 86% WBC purity and 99.99% RBC removal rate in less than 1 min. In addition, the microdevice allows lab-on-chip colorimetric evaluation of chronic granulomatous disease (CGD), a rare genetic disorder affecting globally. The assay duration, straight from separation to disease detection, requires only 20 min. Hence, the proposed microfluidic platform can further be implemented to streamline various clinical procedures involving WBCs in healthcare industries.

Keywords: CGD; Inertial focusing; Lab-on-chip; Micropump; WBCs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Separation* / instrumentation
  • Cell Separation* / methods
  • Granulomatous Disease, Chronic* / blood
  • Granulomatous Disease, Chronic* / diagnosis
  • Humans
  • Lab-On-A-Chip Devices*
  • Leukocytes* / cytology
  • Microfluidic Analytical Techniques* / instrumentation
  • Microfluidic Analytical Techniques* / methods